nebaprubart   Click here for help

GtoPdb Ligand ID: 14574

Synonyms: JJP-1212 | JJP1212
Immunopharmacology Ligand
Compound class: Antibody
Comment: Nebaprubart (JJP-1212) is a potential first-in-class monoclonal antibody that targets Fc alpha receptor (FCAR; CD89).
Peptide sequence matches for the heavy and light chains of nebaprubart are claimed in patent US20230242646 [1]. In this patent, the most likely candidate to be nebaprubart is clone 10E7 humanized VL3 (VH3SQVL3).
Click here for help
References
1. Simons PJ, den Hartog MT, Boon L. (2023)
Humanized Anti-Human CD89 Antibodies and Uses Thereof.
Patent number: US20230242646A1. Assignee: Polpharma Biologics Utrecht BV, JJP Biologics Sp zoo. Priority date: 21/04/2021. Publication date: 03/08/2023.